孤立性远端深静脉血栓与近端深静脉血栓抗凝结局比较
该研究基于Mayo Clinic血管中心与VTE登记数据库,纳入2013年3月至2020年8月超声确诊的急性DVT患者,比较孤立性远端DVT(IDDVT,n=746)与近端DVT(PDVT,n=1176)的VTE复发、大出血和死亡结局,并分析华法林与DOAC的影响。结果显示两组VTE复发和大出血无总体差异,但IDDVT 3个月死亡率更高;DOAC治疗在两组均与更低的VTE复发、大出血和死亡相关。
要点
- IDDVT与PDVT的VTE复发和大出血率总体相似。
- DOAC较华法林在两组均与更低VTE复发、大出血和死亡相关。
核心结论
- IDDVT的VTE复发和大出血率与PDVT相似,但早期死亡率更高。
- DOAC治疗对两组患者的VTE复发、大出血和死亡结局均有正面影响。
研究设计与样本
- 回顾性队列研究,连续纳入2013年3月1日至2020年8月1日超声确诊的急性DVT患者。
- 通过Mayo Clinic Gonda血管中心与VTE登记数据库识别患者,按血栓位置分为IDDVT(n=746)和PDVT(n=1176)。
主要发现
- 随访期间两组VTE复发或大出血无总体差异。
- 死亡独立预测因素包括华法林(vs DOAC)、年龄增长和活动性癌症。
关键数值与推荐
- IDDVT组n=746,PDVT组n=1176。
临床怎么用
- IDDVT抗凝管理可参考PDVT,但需关注早期死亡风险。
- 优先选择DOAC而非华法林可能改善VTE复发、大出血和死亡结局。
- 对合并活动性癌症或高龄患者应加强风险评估。
局限性
- 回顾性研究设计。
- 数据来自单一中心登记数据库。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Isolated, distal deep vein thrombosis (IDDVT) is thought to have low rates of propagation, embolization, and recurrence compared with proximal DVT (PDVT), but the data are limited. OBJECTIVES: The objective of this study was to assess outcomes among patients with IDDVT compared with PDVT. PATIENTS/METHODS: Consecutive patients with ultrasound-confirmed acute DVT (March 1, 2013-August 1, 2020) were identified by reviewing the Mayo Clinic Gonda Vascular Center and VTE Registry databases. Patients were divided into two groups depending on the DVT location (isolated, distal vs. proximal DVT). Outcomes including venous thromboembolism (VTE) recurrence, major bleeding, and death were compared by thrombus location and anticoagulant therapy, warfarin vs. direct oral anticoagulant (DOAC). RESULTS: Isolated, distal deep vein thrombosis (n = 746) was more often associated with recent surgery, major trauma, or confinement (p < .001), whereas patients with PDVT (n = 1176) were more frequently unprovoked, had a prior history of VTE, or active cancer (p < .001). There was no overall difference in VTE recurrence or major bleeding between groups during follow-up. Patients with IDDVT had a higher death rate at 3 months (p = .001) and when propensity scored for cancer (p = .003). Independent predictors of mortality included warfarin (vs. DOAC) therapy, increasing age, and active cancer. DOAC therapy resulted in lower VTE recurrence, major bleeding, and death rates in both groups. CONCLUSION: Outcomes of IDDVT including VTE recurrence and bleeding rates were similar to PDVT despite higher early mortality rates. Outcomes for both groups were positively influenced by the use of DOACs.
引用
- Vlazny DT, Pasha AK, Kuczmik W, et al. Outcome of anticoagulation in isolated distal deep vein thrombosis compared to proximal deep venous thrombosis. J Thromb Haemost. 2021. PMID: 34060224. doi:10.1111/jth.15416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。